Koyfin Home > Directory > Health Care > Kindred Biosciences > Cost of Goods Sold

Kindred Biosciences Cost of Goods Sold Chart (KIN)

Kindred Biosciences annual/quarterly Cost of Goods Sold from 2018 to 2020.
  • Kindred Biosciences Cost of Goods Sold for the quarter ending June 06, 2020 was $0m a 61.71% increase of 0m year over year
  • Kindred Biosciences Cost of Goods Sold for the last 12 months ending June 06, 2020 was $4m a 85.61% increase of 4m year over year
  • Kindred Biosciences Annual Cost of Goods Sold for 2019 was $1m a 44.80% increase of 0m from 2018
  • Kindred Biosciences Annual Cost of Goods Sold for 2018 was $0m
Other Income Statement Metrics:
  • Kindred Biosciences EBITDA for the quarter ending December 12, 2018 was $-16m a 35.48% decrease of -6m year over year
  • Kindred Biosciences Net Income for the quarter ending December 12, 2018 was $-15m a 35.43% decrease of -5m year over year
  • Kindred Biosciences Total Revenue for the quarter ending September 09, 2018 was $1m
View Chart On Koyfin

Quarterly KIN Cost of Goods Sold Data

06/2020$0m
03/2020$4m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m

Annual KIN Cost of Goods Sold Data

2019$1m
2018$0m